Peter A. te Boekhorst

Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial

Ruben A. Mesa, Alessandro M. Vannucchi, Adam J. Mead et al. · The Lancet Haematology · 2017 · 314 citations · Full text

Medicine, Hematology, Pharmacotherapy +9

Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database

Riccardo Saccardi, Tomáš Kozák, Chiara Bocelli‐Tyndall et al. · Multiple Sclerosis Journal · 2006 · 217 citations

Medicine, Hematology, Immunology +16

Incidence of alloantibody formation after ABO‐D or extended matched red blood cell transfusions: a randomized trial (MATCH study)

Henk Schonewille, Áine Honohan, Leo M.G. van der Watering et al. · Transfusion · 2015 · 72 citations

Medicine, Hematology, Surgery +16

A Three-Year Study of Brain Atrophy after Autologous Hematopoietic Stem Cell Transplantation in Rapidly Evolving Secondary Progressive Multiple Sclerosis

Maria A. Rocca, Tjeerd Mondria, Paola Valsasina et al. · American Journal of Neuroradiology · 2007 · 43 citations · Full text

Medicine, Neurology, Neuroscience +13